The Comparison of Guidelines for Management of Dyslipidemia and the Appropriateness of Them in Korea. |
Young Gyu Cho, Hong Ji Song, Byung Ju Park |
1National Evidence-Based Healthcare Collaborating Agency, Seoul, Korea. bjpark@snu.ac.kr 2Department of Family Medicine, Seoul Paik Hospital, College of Medicine, Inje University, Seoul, Korea. 3Hallym Sacred-Heart Hospital, Hallym University College of Medicine, Anyang, Korea. 4Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. |
국내외 이상지질혈증 치료지침의 비교 및 한국인에서의 치료지침의 적절성 |
조영규, 송홍지, 박병주, -지질저하제연구팀 |
1 2 3 4 |
|
|
|
Abstract |
There have been accumulating evidences that dyslipidemia is a major risk factor of cardiovascular disease (CVD) and improvement in lipid profile can reduce the incidence of CVD. Guidelines for management of dyslipidemia have been developed by major organizations in several contries including the United States. In Korea, a guideline was also published by the Korean Society of Lipidology and Atherosclerosis. However, This guideline was not based on evidences in Korea, but was made by a consensus of experts using a pre-developed guideline as a reference. For clinical application for Korean of guidelines developed in different nations, the disease epidemiology and medical environment in Korea should be considered. In this article, we reviewed whether guidelines for management of dyslipidemia are applicable in Korean context. |
Key Words:
Dyslipidemia; Guideline; Cardiovascular Disease; Epidemiology; Lipid-Lowering Agent; Statin |
|